Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001590750-24-000023
Filing Date
2024-11-12
Accepted
2024-11-12 07:15:36
Documents
73
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vrdn-20240930.htm   iXBRL 10-Q 1592490
2 EX-10.1 exhibit101_bi-watchfactory.htm EX-10.1 93710
3 EX-10.2 viridian-paragonamendedand.htm EX-10.2 399833
4 EX-31.1 ex311_2024-09.htm EX-31.1 11377
5 EX-31.2 ex312_2024-09.htm EX-31.2 12579
6 EX-32.1 ex321_2024-09.htm EX-32.1 9365
12 GRAPHIC image_0.jpg GRAPHIC 1342158
13 GRAPHIC image_1.jpg GRAPHIC 52645
14 GRAPHIC image_2.jpg GRAPHIC 161721
  Complete submission text file 0001590750-24-000023.txt   10410874

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrdn-20240930.xsd EX-101.SCH 45612
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrdn-20240930_cal.xml EX-101.CAL 62079
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrdn-20240930_def.xml EX-101.DEF 318932
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrdn-20240930_lab.xml EX-101.LAB 692896
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrdn-20240930_pre.xml EX-101.PRE 483836
76 EXTRACTED XBRL INSTANCE DOCUMENT vrdn-20240930_htm.xml XML 899331
Mailing Address 221 CRESCENT STREET SUITE 103A WALTHAM MA 02453
Business Address 221 CRESCENT STREET SUITE 103A WALTHAM MA 02453 617.272.4600
Viridian Therapeutics, Inc.\DE (Filer) CIK: 0001590750 (see all company filings)

EIN.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36483 | Film No.: 241443252
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)